Stressgen (VSE: SSB) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Stressgen (VSE: SSB)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: William Marsh who wrote (30)	12/8/1997 7:31:00 PM
From: Heat Shock	Read Replies (1) of 236

Stressgen emails: StressGen recently announced that Dr. Richard Young of the Whitehead Institute had published a paper confirming the ability of StressGen's fusion molecules to stimulate the killer T cells necessary to eliminate virus-infected and cancer cells. Further to this announcement, an article has been published in ScienceNOW, the web site of Science magazine. The address is: sciencenow.org The title of the article about Dr. Young's work is: A Shockingly Versatile Vaccine. It was written by Steven Dickman. The site requires a subscription. Can someone with access post a summary? Heat.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next